{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T09:44:19Z","timestamp":1770284659724,"version":"3.49.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,3,31]],"date-time":"2011-03-31T00:00:00Z","timestamp":1301529600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1471-2407-11-117","type":"journal-article","created":{"date-parts":[[2011,4,6]],"date-time":"2011-04-06T14:33:47Z","timestamp":1302100427000},"source":"Crossref","is-referenced-by-count":16,"title":["Retrospective comparison between a regular and a split-dose protocol of 5-fluorouracil, cisplatin, and mitoxantrone for the treatment of far advanced hepatocellular carcinoma"],"prefix":"10.1186","volume":"11","author":[{"given":"Chau-Ting","family":"Yeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Chin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Mu","family":"Sung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Lung","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen-Chun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuang-Tse","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeng-Hwei","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Fu","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,3,31]]},"reference":[{"key":"2610_CR1","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/ijc.1440","volume":"94","author":"DM Parkin","year":"2001","unstructured":"Parkin DM, Bray F, Ferlay J, Pisani P: Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001, 94: 153-6. 10.1002\/ijc.1440.","journal-title":"Int J Cancer"},{"key":"2610_CR2","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.jhep.2006.05.013","volume":"45","author":"JF Perz","year":"2006","unstructured":"Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP: The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006, 45: 529-38. 10.1016\/j.jhep.2006.05.013.","journal-title":"J Hepatol"},{"key":"2610_CR3","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1002\/ijc.2910510402","volume":"51","author":"K Tanaka","year":"1992","unstructured":"Tanaka K, Hirohata T, Takeshita S, Hirohata I, Koga S, Sugimachi K, Kanematsu T, Ohryohji F, Ishibashi H: Hepatitis B virus, cigarette smoking and alcohol consumption in the development of hepatocellular carcinoma: a case-control study in Fukuoka, Japan. Int J Cancer. 1992, 51: 509-14. 10.1002\/ijc.2910510402.","journal-title":"Int J Cancer"},{"key":"2610_CR4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1055\/s-2005-871194","volume":"25","author":"M Sherman","year":"2005","unstructured":"Sherman M: Hepatocellular carcinoma: epidemiology, risk factors, and screening. Semin Liver Dis. 2005, 25: 143-54. 10.1055\/s-2005-871194.","journal-title":"Semin Liver Dis"},{"key":"2610_CR5","first-page":"1460","volume":"55","author":"T Kaido","year":"2008","unstructured":"Kaido T, Uemoto S: Recent evidence in the treatment of small hepatocellular carcinoma. Hepatogastroenterology. 2008, 55: 1460-2.","journal-title":"Hepatogastroenterology"},{"key":"2610_CR6","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1872-034X.2008.00413.x","volume":"39","author":"MW Lai","year":"2009","unstructured":"Lai MW, Huang SF, Lin SM, Chen TC, Lin CY, Yeh CN, Yeh TS, Chen MF, Yeh CT: Expression of the HCRP1 mRNA in HCC as an independent predictor of disease-free survival after surgical resection. Hepatol Res. 2009, 39: 164-76. 10.1111\/j.1872-034X.2008.00413.x.","journal-title":"Hepatol Res"},{"key":"2610_CR7","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/S1542-3565(05)00425-8","volume":"3","author":"M Biselli","year":"2005","unstructured":"Biselli M, Andreone P, Gramenzi A, Trevisani F, Cursaro C, Rossi C, Ricca Rosellini S, Camm\u00e0 C, Lorenzini S, Stefanini GF, Gasbarrini G, Bernardi M: Transcatheter arterial chemoembolization therapy for patients with hepatocellular carcinoma: a case-controlled study. Clin Gastroenterol Hepatol. 2005, 3: 918-25. 10.1016\/S1542-3565(05)00425-8.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2610_CR8","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1365-2036.2006.02704.x","volume":"23","author":"YH Huang","year":"2006","unstructured":"Huang YH, Wu JC, Chen SC, Chen CH, Chiang JH, Huo TI, Lee PC, Chang FY, Lee SD: Survival benefit of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma larger than 10 cm in diameter. Aliment Pharmacol Ther. 2006, 23: 129-35. 10.1111\/j.1365-2036.2006.02704.x.","journal-title":"Aliment Pharmacol Ther"},{"key":"2610_CR9","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1001\/archsurg.141.12.1231","volume":"141","author":"KS Chok","year":"2006","unstructured":"Chok KS, Ng KK, Poon RT, Lam CM, Yuen J, Tso WK, Fan ST: Comparable survival in patients with unresectable hepatocellular carcinoma treated by radiofrequency ablation or transarterial chemoembolization. Arch Surg. 2006, 141: 1231-6. 10.1001\/archsurg.141.12.1231.","journal-title":"Arch Surg"},{"key":"2610_CR10","first-page":"265","volume":"16","author":"Z Haider","year":"2006","unstructured":"Haider Z, ul Haq T, Munir K, Usman MU, Azeemuddin M: Median survival time of patients after transcatheter chemo-embolization for hepatocellular carcinoma. J Coll Physicians Surg Pak. 2006, 16: 265-9.","journal-title":"J Coll Physicians Surg Pak"},{"key":"2610_CR11","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1038\/sj.bjc.6602590","volume":"92","author":"TF Greten","year":"2005","unstructured":"Greten TF, Papendorf F, Bleck JS, Kirchhoff T, Wohlberedt T, Kubicka S, Klempnauer J, Galanski M, Manns MP: Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients. Br J Cancer. 2005, 92: 1862-8. 10.1038\/sj.bjc.6602590.","journal-title":"Br J Cancer"},{"key":"2610_CR12","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/bjs.4045","volume":"90","author":"CB O'Suilleabhain","year":"2003","unstructured":"O'Suilleabhain CB, Poon RT, Yong JL, Ooi GC, Tso WK, Fan ST: Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma. Br J Surg. 2003, 90: 325-31.","journal-title":"Br J Surg"},{"key":"2610_CR13","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/(SICI)1097-0142(20000101)88:1<50::AID-CNCR8>3.0.CO;2-I","volume":"88","author":"L Llad\u00f3","year":"2000","unstructured":"Llad\u00f3 L, Virgili J, Figueras J, Valls C, Dominguez J, Rafecas A, Torras J, Fabregat J, Guardiola J, Jaurrieta E: A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization. Cancer. 2000, 88: 50-7.","journal-title":"Cancer"},{"key":"2610_CR14","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1007\/BF02100123","volume":"41","author":"F Farinati","year":"1996","unstructured":"Farinati F, De Maria N, Marafin C, Hersz\u00e8nyi L, Del Prato S, Rinaldi M, Perini L, Cardin R, Naccarato R: Unresectable hepatocellular carcinoma in cirrhosis: survival, prognostic factors, and unexpected side effects after transcatheter arterial chemoembolization. Dig Dis Sci. 1996, 41: 2332-9. 10.1007\/BF02100123.","journal-title":"Dig Dis Sci"},{"key":"2610_CR15","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1002\/1097-0142(19950515)75:10<2427::AID-CNCR2820751007>3.0.CO;2-J","volume":"75","author":"GF Stefanini","year":"1995","unstructured":"Stefanini GF, Amorati P, Biselli M, Mucci F, Celi A, Arienti V, Roversi R, Rossi C, Re G, Gasbarrini G: Efficacy of transarterial targeted treatments on survival of patients with hepatocellular carcinoma. An Italian experience. Cancer. 1995, 75: 2427-34. 10.1002\/1097-0142(19950515)75:10<2427::AID-CNCR2820751007>3.0.CO;2-J.","journal-title":"Cancer"},{"key":"2610_CR16","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1056\/NEJMoa0708857","volume":"359","author":"JM Llovet","year":"2008","unstructured":"Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz JF, Borbath I, H\u00e4ussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D, Bruix J, SHARP Investigators Study Group: Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008, 359: 378-90. 10.1056\/NEJMoa0708857.","journal-title":"N Engl J Med"},{"key":"2610_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","volume":"10","author":"AL Cheng","year":"2009","unstructured":"Cheng AL, Kang YK, Chen Z, Tsao CJ, Qin S, Kim JS, Luo R, Feng J, Ye S, Yang TS, Xu J, Sun Y, Liang H, Liu J, Wang J, Tak WY, Pan H, Burock K, Zou J, Voliotis D, Guan Z: Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol. 2009, 10: 25-34. 10.1016\/S1470-2045(08)70285-7.","journal-title":"Lancet Oncol"},{"key":"2610_CR18","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1634\/theoncologist.11-7-790","volume":"11","author":"AX Zhu","year":"2006","unstructured":"Zhu AX: Systemic therapy of advanced hepatocellular carcinoma: how hopeful should we be?. Oncologist. 2006, 11: 790-800. 10.1634\/theoncologist.11-7-790.","journal-title":"Oncologist"},{"key":"2610_CR19","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1002\/cncr.20841","volume":"103","author":"M Ikeda","year":"2005","unstructured":"Ikeda M, Okusaka T, Ueno H, Takezako Y, Morizane C: A phase II trial of continuous infusion of 5-fluorouracil, mitoxantrone, and cisplatin for metastatic hepatocellular carcinoma. Cancer. 2005, 103: 756-62. 10.1002\/cncr.20841.","journal-title":"Cancer"},{"key":"2610_CR20","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s00535-003-1303-8","volume":"39","author":"TS Yang","year":"2004","unstructured":"Yang TS, Chang HK, Chen JS, Lin YC, Liaw CT, Chang WC: Chemotherapy using 5-fluorouracil, mitoxantrone, and cisplatin for patients with advanced hepatocellular carcinoma: an analysis of 63 cases. J Gastroenterol. 2004, 39: 362-369. 10.1007\/s00535-003-1303-8.","journal-title":"J Gastroenterol"},{"key":"2610_CR21","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.ejca.2008.02.018","volume":"44","author":"JH Wang","year":"2008","unstructured":"Wang JH, Changchien CS, Hu TH, Lee CM, Kee KM, Lin CY, Chen CL, Chen TY, Huang YJ, Lu SN: The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma - Survival analysis of 3892 patients. Eur J Cancer. 2008, 44: 1000-6. 10.1016\/j.ejca.2008.02.018.","journal-title":"Eur J Cancer"},{"key":"2610_CR22","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1080\/07357900600705599","volume":"24","author":"D Stempak","year":"2006","unstructured":"Stempak D, Seely D, Baruchel S: Metronomic dosing of chemotherapy: applications in pediatric oncology. Cancer Invest. 2006, 24: 432-43. 10.1080\/07357900600705599.","journal-title":"Cancer Invest"},{"key":"2610_CR23","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1111\/j.1478-3231.2006.01309.x","volume":"26","author":"CH Chen","year":"2006","unstructured":"Chen CH, Chang TT, Cheng KS, Su WW, Yang SS, Lin HH, Wu SS, Lee CM, Changchien CS, Chen CJ, Sheu JC, Chen DS, Lu SN: Do young hepatocellular carcinoma patients have worse prognosis? The paradox of age as a prognostic factor in the survival of hepatocellular carcinoma patients. Liver Int. 2006, 26: 766-73. 10.1111\/j.1478-3231.2006.01309.x.","journal-title":"Liver Int"},{"key":"2610_CR24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/jmv.1890260103","volume":"26","author":"Y Tanaka","year":"1988","unstructured":"Tanaka Y, Esumi M, Shikata T: Frequent integration of hepatitis B virus DNA in noncancerous liver tissue from hepatocellular carcinoma patients. J Med Virol. 1988, 26: 7-14. 10.1002\/jmv.1890260103.","journal-title":"J Med Virol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-11-117.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-11-117\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-11-117","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,7,12]],"date-time":"2016-07-12T16:13:27Z","timestamp":1468340007000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-11-117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,31]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["2610"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-11-117","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,31]]},"article-number":"117"}}